However, recent evidence indicates that the anti-cancer effects of p53 can be undermined when persistent cell cycle arrest and accumulation of senescent cells leads to the acquisition of a senescence-associated secretory phenotype (SASP). This evidence concerns the gene TP53 and cancer.